Mary Collins (immunologist)

Last updated
Mary Collins
Born
Mary Katharine Levinge Collins
NationalityBritish
Alma mater
Known forDevelopment of lentivirus viral vectors
Spouse
​
(m. 1995)​
[1]
ChildrenTwo daughters, [1] born c. 1994 and 1998
Awards FMedSci
Scientific career
Fields Immunology
Institutions
Thesis The mechanism of action of mitogens for cultured murine fibroblasts : regulation of mitogenic receptors and response  (1983)
Academic advisorsEnrique Rozengurt, Richard C. Mulligan
Website iris.ucl.ac.uk/iris/browse/profile?upi=MKLCO33

Mary Katharine Levinge Collins, Lady Hunt is a British Professor of virology and the director of the Queen Mary University of London Blizard Institute. She served as Provost at the Okinawa Institute of Science and Technology in Japan. Formerly, Collins taught in the Division of Infection and Immunity at University College London, and was the head of the Division of Advanced Therapies at the National Institute for Biological Standards and Control, and the Director of the Medical Research Council Centre for Medical Molecular Virology. Her research group studies the use of viruses as vectors for introducing new genes into cells, which can be useful for experimental cell biology, for clinical applications such as gene therapy, and as cancer vaccines. [2] [3] [4] [5] [6]

Contents

Education

Collins was born in Reading, England and grew up in Cheltenham Spa, attending Cheltenham Ladies' College as a day girl. She won an entrance scholarship to Clare College, Cambridge, where she studied Natural Sciences (Biochemistry).[ citation needed ] She did her postgraduate research work supervised by Enrique Rozengurt at the Imperial Cancer Research Fund for which she was awarded a PhD by the University of London in 1983. [7]

Career and research

After her PhD, she moved to a postdoctoral fellowship with Avrion Mitchison at University College London studying the locations of T cell receptor gene clusters, and next worked with Richard C. Mulligan at the Whitehead Institute at the Massachusetts Institute of Technology, where she developed retroviral vectors expressing cytokines and cytokine receptors. [3]

Collins started her research group in 1987 at the Institute of Cancer Research in London and moved in 1997 to University College London, where she has since held a variety of leadership positions. She served as the head of UCL Immunology & Molecular Pathology from 2000 to 2007, became Director of the Medical Research Council Centre for Medical Molecular Virology in 2005, became Director of the UCL Division of Infection & Immunity in 2003, and served as the Dean of the Faculty of Life Sciences between 2009 and 2014. She stepped down as dean to become the head of the Division of Advanced Therapies at the National Institute for Biological Standards and Control. [3] [8]

Collins was among the prominent UCL women scientists featured in a series of interviews published by the MRC in celebration of International Women's Day in 2011 [9] and was one of two UCL women to participate in a women in science event in collaboration with Central Saint Martins College of Art and Design in 2012. In December 2015, it was announced that Professor Collins would become Dean of Research at the Okinawa Institute of Technology. Forbes Magazine speculated that she would supervise of $110m in Japanese government funding at the Institute. [10] [11] She was appointed Provost in 2018 and lead the University's response to the COVID-19 pandemic.

In October 2022, she returned to London to take up the post of Director of the Blizard Institute, Queen Mary University of London. [12]

Collins' research group studies the use of viruses, particularly lentiviruses (the group to which the human immunodeficiency virus belongs), as vectors for delivering novel genes to cells and as platforms for the development of vaccines. [2] Because lentiviruses like HIV specifically infect immune cells called T-cells, a genetically engineered inactivated version of the virus can be used to deliver immunogenic proteins to T-cells to induce an immune response. This system has been studied successfully in laboratory mice. [13] [14]

Awards and honours

Collins was elected a Fellow of the Academy of Medical Sciences (FMedSci)in 1999. [3]

She won the Suffrage Science award in 2011. [15]

Personal

Collins married Tim Hunt in 1995, [1] who was awarded the Nobel Prize in Physiology or Medicine in 2001, and knighted in 2006. They have two children. [16]

Related Research Articles

<i>Adenoviridae</i> Family of viruses

Adenoviruses are medium-sized, nonenveloped viruses with an icosahedral nucleocapsid containing a double-stranded DNA genome. Their name derives from their initial isolation from human adenoids in 1953.

Lentivirus is a genus of retroviruses that cause chronic and deadly diseases characterized by long incubation periods, in humans and other mammalian species. The genus includes the human immunodeficiency virus (HIV), which causes AIDS. Lentiviruses are distributed worldwide, and are known to be hosted in apes, cows, goats, horses, cats, and sheep as well as several other mammals.

<span class="mw-page-title-main">Viral vector</span> Biotechnology to deliver genetic material into a cell

Viral vectors are modified viruses designed to deliver genetic material into cells. This process can be performed inside an organism or in cell culture. Viral vectors have widespread applications in basic research, agriculture, and medicine.

<span class="mw-page-title-main">Janice E. Clements</span> American biologist, academic and medical researcher

Janice Ellen Clements is vice dean for faculty at the Johns Hopkins School of Medicine and the Mary Wallace Stanton Professor of Faculty Affairs. She is a professor in the departments of Molecular and Comparative Pathobiology, Neurology, and Pathology, and has a joint appointment in molecular biology and genetics. Her molecular biology and virology research examines lentiviruses and how they cause neurological diseases.

Ann M. Arvin is an American pediatrician and microbiologist. She is the Lucile Salter Packard Professor of Pediatrics and Professor of Microbiology & Immunology Emerita at Stanford University. Arvin is a specialist of the Varicella zoster virus (VZV) and a prominent national figure in health. Arvin is currently the chief of the infectious diseases division of pediatrics at the Lucile Packard Children's Hospital, as well as the former Stanford's Vice Provost and Dean of Research.

Herpes simplex research includes all medical research that attempts to prevent, treat, or cure herpes, as well as fundamental research about the nature of herpes. Examples of particular herpes research include drug development, vaccines and genome editing. HSV-1 and HSV-2 are commonly thought of as oral and genital herpes respectively, but other members in the herpes family include chickenpox (varicella/zoster), cytomegalovirus, and Epstein-Barr virus. There are many more virus members that infect animals other than humans, some of which cause disease in companion animals or have economic impacts in the agriculture industry.

Thumbi Ndung’u is a Kenyan-born HIV/AIDS researcher. He is the deputy director (Science) and a Max Planck Research Group Leader at the Africa Health Research Institute (AHRI) in Durban, South Africa. He is Professor of Infectious Diseases in the Division of Immunity and Infection, University College London. He is Professor and Victor Daitz Chair in HIV/TB Research and Scientific Director of the HIV Pathogenesis Programme (HPP) at the Nelson R. Mandela School of Medicine, University of KwaZulu-Natal. He holds the South African Research Chair in Systems Biology of HIV/AIDS. He is an adjunct professor of Immunology and Infectious Diseases at the Harvard T.H. Chan School of Public Health. He is the Programme Director of the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE), a research and capacity building initiative funded by the African Academy of Sciences and the Wellcome Trust.

<span class="mw-page-title-main">Lentiviral vector in gene therapy</span>

Lentiviral vectors in gene therapy is a method by which genes can be inserted, modified, or deleted in organisms using lentiviruses.

<span class="mw-page-title-main">Wendy Barclay</span> British virologist

Wendy Sue Fox is a British virologist. She is currently head of Department of Infectious Disease and chair in Influenza Virology at Imperial College London. She leads a team of scientists studying the influenza virus and its physiology and morphology to discover novel vaccines. In particular, they are trying to understand more about influenza virus mutations, and how they can allow scientists to create new vaccines against possible flu pandemics.

Anna-Lise WilliamsonMASSAf is a Professor of Virology at the University of Cape Town. Williamson obtained her PhD from the University of the Witwatersrand in 1985. Her area of expertise is human papillomavirus, but is also known on an international level for her work in developing vaccines for HIV. These vaccines have been introduce in phase 1 of clinical trial. Williamson has published more than 120 papers.

Polly Roy OBE is a professor and Chair of Virology at The London School of Hygiene and Tropical Medicine. She attended a number of schools which included Columbia University Medical School, Rutgers University, University of Alabama, and University of Oxford. In 2001 she became a part of The London School of Hygiene and Tropical Medicine and, along with being the chair of Virology, is also the co-organiser of the medical microbiology course. The virus that she has dedicated most of her career to is Bluetongue disease that affects sheep and cattle. She became interested in this virus after attending a symposium and was intrigued by the fact that not much was known about the virus that was causing such a nasty and sometimes fatal disease.

Julianna Lisziewicz is a Hungarian immunologist. Lisziewicz headed many research teams that have discovered and produced immunotheraputic drugs to treat diseases like cancer and chronic infections like HIV/AIDS. Some of these drugs have been successfully used in clinical trials.

Pierre Charneau is a French virologist, inventor, and head of the Molecular Virology and Vaccinology Unit (VMV) at the Pasteur Institute and an acknowledged specialist in HIV, lentiviral gene transfer vectors, and their medical applications. His discovery of the central DNA-flap structure in the HIV genome, and its role in viral entry into the nucleus of the infected cell, grounded the optimization of lentiviral vectors and allowed for more than 20 years of development in gene therapy and vaccines based on this gene delivery technology. Charneau has published more than 100 research articles and holds 25 patents in the field of HIV and lentiviral vectors.

Professor Ravindra "Ravi" Kumar Gupta is a professor of clinical microbiology at the Cambridge Institute of Therapeutic Immunology and Infectious Disease at the University of Cambridge. He is also a member of the faculty of the Africa Health Research Institute in Durban, South Africa.

Judith Breuer is a British virologist who is professor of virology and director of the Pathogen Genomics Unit at University College London. She was elected a Fellow of the Academy of Medical Sciences in 2019. Breuer is part of the United Kingdom genome sequencing team that looks to map the spread of the coronavirus disease 2019.

<span class="mw-page-title-main">Vanessa M. Hirsch</span> Canadian-American veterinary pathologist and scientist

Vanessa M. Hirsch is a Canadian-American veterinary pathologist and scientist. She is a senior investigator and chief of the nonhuman primate virology section at the National Institute of Allergy and Infectious Diseases. Hirsch researches AIDS pathogenesis, the evolution and origins of primate lentiviruses, and HIV vaccine development.

Mavis Agbandje-McKenna was a Nigerian-born British medical biophysicist, structural virologist, and a professor of structural biology, as well as the director of the Center for Structural Biology at the University of Florida in Gainesville, Florida. Agbandje-McKenna studied parvovirus structures using X-ray crystallography and cryogenic electron microscopy and did much of the initial work to elucidate the basic structure and function of adeno-associated viruses (AAVs). Her viral characterization and elucidation of antibody binding sites on AAV capsids has led to the development of viral capsid development and gene therapy approaches that evade immune detection and can be used to treat human diseases such as muscular dystrophies. Agbandje-McKenna was recognized with the 2020 American Society of Gene and Cell Therapy Outstanding Achievement Award for her contributions to the field. She died in 2021 from amyotrophic lateral sclerosis.

Theodora Hatziioannou is a Greek-American virologist. She known for her work discovering restriction factors that counteract HIV-AIDS and other primate lentiviruses, thus restricting them to specific species, and making it hard to study HIV-1 in animals. Her findings allowed her to develop the first HIV-1-based virus which is capable of recapitulating AIDS-like symptoms in a non-hominid. She is a Research Associate Professor in the Laboratory of Retrovirology at The Rockefeller University in New York. She is a co-author of a textbook on virology, Principles of Virology.

<span class="mw-page-title-main">Viral vector vaccine</span> Type of vaccine

A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, to elicit an immune response. As of April 2021, six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans.

William Paul Duprex is a British scientist and advocate for vaccines and global health. He serves as Director of the University of Pittsburgh's Center for Vaccine Research and Regional Biocontainment Laboratory. Duprex holds the Jonas Salk Chair in Vaccine Research. He is also a professor of microbiology and molecular genetics at the University of Pittsburgh School of Medicine and serves as Editor-in-Chief of the Journal of General Virology, which is published by the Microbiology Society, and a senior editor of mSphere, published by the American Society for Microbiology. Duprex is an expert in measles and mumps viruses and studies viral spillover from animals to humans, including the SARS-CoV-2 virus that caused the COVID-19 pandemic. Duprex is a Fellow of the American Academy of Microbiology.

References

  1. 1 2 3 "HUNT, Sir Tim" . Who's Who . Vol. 1992 (online Oxford University Press  ed.). A & C Black.(Subscription or UK public library membership required.)
  2. 1 2 "Prof Mary Collins". University College London. Archived from the original on 15 June 2015. Retrieved 11 June 2015.
  3. 1 2 3 4 "Professor Mary Collins". National Institute for Biological Standards and Control. Retrieved 11 June 2015.
  4. ↑ "People, Medical Molecular Virology". University College London. Archived from the original on 13 June 2015. Retrieved 11 June 2015.
  5. ↑ "Mary Collins website @UCL". ucl.ac.uk. Archived from the original on 2015-06-15.
  6. ↑ "Mary Collins appointed as Director of Queen Mary's Blizard Institute". EurekAlert!.
  7. ↑ Collins, Mary Katharine Levinge (1983). The mechanism of action of mitogens for cultured murine fibroblasts : regulation of mitogenic receptors and response (PhD thesis). University of London. OCLC   941030795.
  8. ↑ "New leadership team for the UCL School of Life & Medical Sciences". University College London. 30 June 2009. Retrieved 11 June 2015.
  9. ↑ "Leading UCL researchers celebrate women's contribution to science". University College London. 10 March 2011. Retrieved 11 June 2015.
  10. ↑ "Women in Science: Nurturing Nobels". University College London. 12 March 2012. Retrieved 11 June 2015.
  11. ↑ Robin McKie (2015-12-19). "Tim Hunt and Mary Collins: 'We're not being chased out of the country. Our new life's an adventure'". The Guardian . Retrieved 2015-12-28.
  12. ↑ Mary Collins appointed as Director of Queen Mary's Blizard Institute, qmul.ac.uk. Accessed 12 December 2022.
  13. ↑ Collins, MK; Cerundolo, V (December 2004). "Gene therapy meets vaccine development". Trends in Biotechnology. 22 (12): 623–6. doi:10.1016/j.tibtech.2004.10.006. PMID   15542151.
  14. ↑ McKie, Robin (23 April 2011). "Mary Collins: HIV can help fight disease". The Guardian. Retrieved 11 June 2015.
  15. ↑ "UCL scientists to be recognised at Suffrage Science event". UCL News. 28 February 2013.
  16. ↑ "Biozentrum Lectures 2010". Universität Basel. Retrieved 11 June 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.